A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2007
11/08/2007	WO2007127354A2 Homogeneous dispersions containing citrus pulp and applications thereof
11/08/2007	WO2007127158A2 Modification of percutaneous absorption of topically active materials
11/08/2007	WO2007126808A1 Pegylated factor viii
11/08/2007	WO2007126732A2 Ruminant feed composition and method of making
11/08/2007	WO2007126154A1 Method of producing polysaccharide derivatives
11/08/2007	WO2007126110A1 Method of producing polymer micelle having low molecular chemical encapsulated therein
11/08/2007	WO2007126067A1 Nonaqueous pressure-sensitive adhesive composition, patches and process for production of patches
11/08/2007	WO2007126063A1 Granulated particle, tablet and method for producing granulated particle
11/08/2007	WO2007126048A1 Process for producing homogeneous and stable suspension and apparatus therefor
11/08/2007	WO2007126039A1 Coated macrolide antibiotic preparation
11/08/2007	WO2007125915A1 Solid matter containing coenzyme q
11/08/2007	WO2007125888A1 Liquid composition for oral dosage
11/08/2007	WO2007125731A1 Soft contact lens solution, drug-sustained release soft contact lens prepared by using the solution
11/08/2007	WO2007125653A1 Oral liquid composition containing crude drug
11/08/2007	WO2007125545A2 Transmucosal composition
11/08/2007	WO2007125501A2 Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
11/08/2007	WO2007125318A1 Non-aqueous liquid formulation for nasal or buccal administration
11/08/2007	WO2007125089A2 Antibodies for the detection of bacillus anthracis and vaccine against b. anthracis infections
11/08/2007	WO2007125028A1 Method for solubilising hydrophobic active substances in an aqueous medium
11/08/2007	WO2007124668A1 Pharmaceutical composition comprising high concentrate of polydatin
11/08/2007	WO2007124598A2 Softgel capsules with phytosterols and/or phytostanols and optionlly omega polyunstaurated fatty acids
11/08/2007	WO2007124572A1 Electrolyte solution and method for electrolytic co-deposition of thin film calcium phosphate and drug composites
11/08/2007	WO2007124537A1 Biodegradable implants for bone fusion and compositions therefor
11/08/2007	WO2007104768A3 Di-polymer protein conjugates and processes for their preparation
11/08/2007	WO2007100385A3 Macrocyclic depsipeptide antibody-drug conjugates and methods
11/08/2007	WO2007096733A3 Desloratadine-containing formulation stabilized with cyclodextrin
11/08/2007	WO2007076274A3 Artificial tear solution containing poly (ethylene glycol) peg lipids
11/08/2007	WO2007075534A3 Polymer conjugates of glp-1
11/08/2007	WO2007030545A3 Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates
11/08/2007	WO2007028258A3 Interpenetrating networks, and related methods and compositions
11/08/2007	WO2007025388A3 Anti-apoptotic protein antibodies
11/08/2007	WO2007020085A3 Compositions containing taxane derivatives for intravenous injection
11/08/2007	WO2007019331A3 Conjugates of a g-csf moiety and a polymer
11/08/2007	WO2005009394A3 Drug delivery in the nervous system
11/08/2007	US20070260038 Preparation of microparticles having improved flow ability
11/08/2007	US20070259968 Macroporous Plastic Bead
11/08/2007	US20070259931 Process of reducing the bitter taste of water soluble actives by co-grinding the acitve with beta cyclodextrin
11/08/2007	US20070259889 Protein Binding Compounds
11/08/2007	US20070259843 Methods and Compositions for Treatment of Macular and Retinal Disease
11/08/2007	US20070259834 Dermally Applicable Liquid Formulations for Controlling Parasitic Arthropods on Animals
11/08/2007	US20070259098 Water soluble, gelatin-free dip coatings for pharmaceutical solid dosage forms such as tablets comprising hydroxypropylmethyl cellulose and xanthan gum, carrageenan, and mixtures thereof, or hydroxypropylmethyl cellulose and castor oil or maltodextrin
11/08/2007	US20070259050 Combined Cosmetic or Therapeutic Preparation
11/08/2007	US20070259048 Mixture of micronized formoterol fumarate dihydrate salt (< 0.6 w/w) and a micronised pharmaceutically acceptable carrier/diluent, lactose; high storage stability such that the decomposition of formoterol will be < 2.0% (w/w) when stored in a powder device at 40 degrees C. and 75% relative humidity
11/08/2007	US20070259047 Protein Sustained-Release Microparticle Preparation for Injection and Process for Producing the Same
11/08/2007	US20070259036 Lactic acid polymer and process for producing the same
11/08/2007	US20070259023 Insulin compensated nutrition
11/08/2007	US20070259022 Composition Comprising Statin
11/08/2007	US20070259009 Aqueous Pharmaceutical Preparation Comprising Roflumilast
11/08/2007	US20070259008 Polymalic Acid-Based Multi-Functional Drug Delivery System
11/08/2007	US20070259005 Method of treating cancer
11/08/2007	US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007	US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007	US20070258986 Targeted Delivery System for Bioactive Agents
11/08/2007	US20070258969 Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
11/08/2007	US20070258968 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
11/08/2007	US20070258942 C-Nitroso compounds and use thereof
11/08/2007	US20070258920 Process for obtaining polyphenol extracts from cocoa beans, the resulting extracts and uses thereof
11/08/2007	US20070258906 Methods and devices for detection and therapy of atheromatous plaque
11/08/2007	US20070258891 Conjugates of N-Hydroxypropymethacrylamide-Methacrylate Copolymer with Nuclide Activation Agent and/or Anti-Cancer Compounds
11/08/2007	CA2803111A1 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
11/08/2007	CA2651102A1 Method of producing polysaccharide derivatives
11/08/2007	CA2650459A1 Antibodies for the detection of bacillus anthracis and vaccine against b. anthracis infections
11/08/2007	CA2650422A1 Process for producing polymer micelles encapsulating low molecular weight drugs
11/08/2007	CA2650056A1 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
11/08/2007	CA2650040A1 Transmucosal composition
11/08/2007	CA2649471A1 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
11/08/2007	CA2648670A1 Electrolyte solution and method for electrolytic co-deposition of thin film calcium phosphate and drug composites
11/08/2007	CA2647314A1 Pegylated factor viii
11/08/2007	CA2646048A1 Compositions and methods of use for antibodies of c-met
11/07/2007	EP1852443A1 Biocompatible three dimensional matrix for the immobilization of biological substances
11/07/2007	EP1852178A1 Process for producing coated fine particle
11/07/2007	EP1852177A1 Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
11/07/2007	EP1852130A1 Medicine for external application containing anti-inflammatory agent and soy lecithin
11/07/2007	EP1852128A1 An anti HSP90 antibody
11/07/2007	EP1852120A1 Ointment
11/07/2007	EP1852118A1 Method for producing adsorptive porous body
11/07/2007	EP1852116A1 Pharmaceutical compositions of amlodipine and atorvastatin
11/07/2007	EP1852115A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
11/07/2007	EP1852111A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
11/07/2007	EP1852106A1 Solid ophthalmic drug for external use
11/07/2007	EP1850878A2 C-terminally pegylated growth hormones
11/07/2007	EP1850877A1 Process for the preparation of alkoxyamine functionalised polyethylene glycols
11/07/2007	EP1850876A1 Transport of nano- and macromolecular structures into cytoplasm and nucleus of cells
11/07/2007	EP1850875A1 Sustained release composition of protein drug
11/07/2007	EP1850870A1 Composition for adjuvant containing poly-gamma-glutamic acid
11/07/2007	EP1850850A2 Compositions and methods for targeted delivery of immune response modifiers
11/07/2007	EP1850831A2 Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
11/07/2007	EP1850830A1 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
11/07/2007	EP1850828A2 Spreadable warming lubricant
11/07/2007	EP1790357A4 Perorally administrable antimicrobial composition
11/07/2007	EP1732953B1 Hydroxyethyl starch
11/07/2007	EP1576961B1 Use of silymarin and carbopol as a regenerator of pancreatic tissue and cells with endocrine secretion damaged by diabetes mellitus
11/07/2007	EP1414414B1 Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers
11/07/2007	EP1399192B1 Conjugates of polysaccharide polymers of natural origin
11/07/2007	EP1276473B1 Pharmaceutical formulations for dry powder inhalers
11/07/2007	EP1017413B2 Liquid interferon-beta formulations
11/07/2007	EP0979071B1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
11/07/2007	CN101068577A Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy
11/07/2007	CN101068573A Topical nepafenac formulations
11/07/2007	CN101068572A Anti-snoring composition

1 ... 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 ... 1712